Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Purpose Canadian Financial Income Series A T.BNC

The fund seeks to provide shareholders with (i) long-term capital appreciation through investment in a portfolio of Canadian Banks (defined below) (up to 70% on an equal weighted basis) and Canadian Insurance Companies (defined below) (up to 30% on an equal weighted basis) and (ii) monthly distributions.To achieve its investment objectives, the fund will invest primarily in equity securities of... see more

TSX:BNC - Post Discussion

View:
Post by vega509 on Oct 11, 2016 11:07am

voted NO

I received my proxy today, and promptly voted NO.

I doubt this give away will be voted down. IMO both management and the board have shorted shareholders while enriching themselves, and likely moreso in a backroom deal.

best of luck to all
Comment by PSB on Oct 11, 2016 11:29am
Same here. I just voted NO in all accounts, although I know it won't make a difference in the end. I had to do it for my own peace of mind. Unfortunately this "vote" is just a formality for our illustrious management team. Good luck to all
Comment by skyhigh123 on Oct 11, 2016 11:46am
This post has been removed in accordance with Community Policy
Comment by vega509 on Oct 11, 2016 12:08pm
are you going to add your 1 share??
Comment by skyhigh123 on Oct 11, 2016 12:10pm
This post has been removed in accordance with Community Policy
Comment by 1wascallywabbit on Oct 11, 2016 6:08pm
I just voted a resounding NO, NO, NO.....with multiple 7 figure share/accounts. Go to Zero and be damned!!!
Comment by robergea on Oct 12, 2016 8:37pm
FYI, I do not own TST but I do own PLI. Regarding the vote/deal, I am not convinced that it will go through. I assume that K2 will vote NO after building a big position. They own a significant portion of the o/s shares. I am not sure who are the top 5 shareholders but if K2 can convince them then the result could be a NO. The other reason for K2 to buy would be arbitrage but I would doubt it. Few ...more  
Comment by Dibah42 on Oct 13, 2016 10:36am
robergea:  Why do you assume that K2 built up their big position in order to put the kaibosh on the deal? Isn't it possible that their motivation to acquire PLI is the same as yours?  "They should do well in the future".
Comment by robergea on Oct 13, 2016 11:43pm
Maybe "assume" was a strong word. Probably better to say I would think that K2.... They are an activist fund so they may want to get in and get a better price for TST than what PLI offered. If they wanted PLI they could buy them in the market at possibly lower price than it will be at the closure of the deal. JMHO.
Comment by Biostocks01 on Oct 14, 2016 12:40am
Ipsen Pharma was the last hope for the MCA and the shareholders of TST...they showed no interest!! Stop dreaming in color...there will be no other offers!! If Shareholders Vote againts the Plan of Arrangement between Telesta Therapeutics Inc. and ProMetic Life Sciences Inc....they will lose their entire investment!! period! Bio
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities